INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy
International Report on Routine Practice of Sensor-enabled Pump Therapy
Sponsor: Medtronic Diabetes
Listed as NCT00790088, this observational or N/A phase trial focuses on Diabetes Mellitus, Type 1 and remains completed. Sponsored by Medtronic Diabetes, it has been updated 12 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Mar 2019 — Nov 2020 [monthly]
Completed
Status: Unknown Status → Completed
-
Jun 2018 — Mar 2019 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
Feb 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Diabetes
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Antwerp, Belgium , Badajoz, Spain , Belgrade, Serbia , Bialystok, Poland , Bonheiden, Belgium , Budapest, Hungary , Békéscsaba, Hungary , Dax, France , Fredericia, Denmark , Gliwice, Poland and 16 more locations